Evidence map›Paper›PMID 19255227›Full record

ArticleThe Journal of bone and joint surgery. American volume2009

Identification of progenitor cells that contribute to heterotopic skeletogenesis.

Vitali Y Lounev, Rageshree Ramachandran, Michael N Wosczyna, Masakazu Yamamoto, Andrew D A Maidment, Eileen M Shore, David L Glaser, David J Goldhamer, Frederick S Kaplan

Open access · greenAbstract read
In one paragraph

Article in The Journal of bone and joint surgery. American volume, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 170 papers.

0numbers the graph read from it
0cells of the map it votes in
170citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

170 citing papers in PubMed, 296 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Identification of a Tenochondral Ossification Sequence Producing Heterotopic Ossification in Human Achilles Tendinopathy.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. A Focal Ophthalmic Lesion in a New Zealand White Rabbit (Oryctolagus cuniculus).Journal of the American Association for Laboratory Animal Science : JAALAS · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

110 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Vitali Y LounevDepartment of Orthopaedic Surgery, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.
Rageshree Ramachandran
Michael N Wosczyna
Masakazu Yamamoto
Andrew D A Maidment
Eileen M Shore
David L Glaser
David J Goldhamer
Frederick S Kaplan
University of Connecticut · USPhiladelphia University · USHospital of the University of Pennsylvania · USUniversity of California, San Francisco · USUniversity of Pennsylvania · US

Funding

The Cellular and Molecular Basis of FOP LesionsR01AR041916 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI KAPLAN, FREDERICK SAMUEL, SHORE, EILEEN M · 1994 to 2014
$3.8M
Osteogenic Progenitor Cells in Skeletal MuscleR01AG020911 · NIA · UNIVERSITY OF PENNSYLVANIA · PI GOLDHAMER, DAVID J · 2001 to 2005
$1.5M
NIAMS NIH HHS R01 AR041916NIAMS NIH HHS R01-AR41916NIA NIH HHS R01-AG20911
6 · The paper itself

Abstract

backgroundIndividuals who have fibrodysplasia ossificans progressiva develop an ectopic skeleton because of genetic dysregulation of bone morphogenetic protein (BMP) signaling in the presence of inflammatory triggers. The identity of progenitor cells that contribute to various stages of BMP-induced heterotopic ossification relevant to fibrodysplasia ossificans progressiva and related disorders is unknown. An understanding of the cellular basis of heterotopic ossification will aid in the development of targeted, cell-specific therapies for the treatment and prevention of heterotopic ossification.

methodsWe used Cre/loxP lineage tracing methods in the mouse to identify cell lineages that contribute to all stages of heterotopic ossification. Specific cell populations were permanently labeled by crossing lineage-specific Cre mice with the Cre-dependent reporter mice R26R and R26R-EYFP. Two mouse models were used to induce heterotopic ossification: (1) intramuscular injection of BMP2/Matrigel and (2) cardiotoxin-induced skeletal muscle injury in transgenic mice that misexpress BMP4 at the neuromuscular junction. The contribution of labeled cells to fibroproliferative lesions, cartilage, and bone was evaluated histologically by light and fluorescence microscopy. The cell types evaluated as possible progenitors included skeletal muscle stem cells (MyoD-Cre), endothelium and endothelial precursors (Tie2-Cre), and vascular smooth muscle (Smooth Muscle Myosin Heavy Chain-Cre [SMMHC-Cre]).

resultsVascular smooth muscle cells did not contribute to any stage of heterotopic ossification in either mouse model. Despite the osteogenic response of cultured skeletal myoblasts to BMPs, skeletal muscle precursors in vivo contributed minimally to heterotopic ossification (<5%), and this contribution was not increased by cardiotoxin injection, which induces muscle regeneration and mobilizes muscle stem cells. In contrast, cells that expressed the vascular endothelial marker Tie2/Tek at some time in their developmental history contributed robustly to the fibroproliferative, chondrogenic, and osteogenic stages of the evolving heterotopic endochondral anlagen. Importantly, endothelial markers were expressed by cells at all stages of heterotopic ossification. Finally, muscle injury and associated inflammation were sufficient to trigger fibrodysplasia ossificans progressiva-like heterotopic ossification in a setting of chronically stimulated BMP activity.

conclusionsTie2-expressing progenitor cells, which are endothelial precursors, respond to an inflammatory trigger, differentiate through an endochondral pathway, contribute to every stage of the heterotopic endochondral anlagen, and form heterotopic bone in response to overactive BMP signaling in animal models of fibrodysplasia ossificans progressiva. Thus, the ectopic skeleton is not only supplied by a rich vasculature, but appears to be constructed in part by cells of vascular origin. Further, these data strongly suggest that dysregulation of the BMP signaling pathway and an inflammatory microenvironment are both required for the formation of fibrodysplasia ossificans progressiva-like lesions.

Indexed as

AnimalsBone Morphogenetic Protein 2Cell LineageDisease Models, AnimalEndothelium, VascularImmunohistochemistryInjections, IntramuscularMiceMice, TransgenicMuscle, Smooth, VascularMyoblastsMyoD ProteinMyositis OssificansOssification, HeterotopicReceptor Protein-Tyrosine KinasesReceptor, TIE-2Bmp2 protein, mouseBone Morphogenetic Protein 2MyoD1 myogenic differentiation proteinMyoD ProteinReceptor Protein-Tyrosine KinasesReceptor, TIE-2Tek protein, mouse

Identifiers

PMID19255227
PMCPMC2663346
OpenAlexW2113679184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.